TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32213659

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy (TRT) - Testosterone undecanoate injection three times/6 months (n = 20)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (n = 21)
Number of subjects: 41
Study: 34653515

Group type: EXPERIMENTAL
Intervention: Peanut Epicutaneous Immunotherapy (49 participants)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Egg Oral Immunotherapy or Baked Egg Diet (92 participants)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Baseline type 2 cells
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Baseline egg-specific type 2 cell frequency
Number of subjects: 226
Study: 35291842

Group type: EXPERIMENTAL
Intervention: Pericapsular nerve group (PENG) block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Femoral nerve block (FNB)
Number of subjects: 60
Study: 32493387

Group type: EXPERIMENTAL
Intervention: MIPS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 35350000

Group type: EXPERIMENTAL
Intervention: AFCs + collagen
Number of subjects: 10

Group type: COMPARATOR
Intervention: AFCs only
Number of subjects: 10
Study: 34464306

Group type: EXPERIMENTAL
Intervention: levobupivacaine 0.5 mg/kg plus 1?g/kg dexmedetomidine and 0.9% isotonic (Group 4)
Number of subjects: 60

Group type: COMPARATOR
Intervention: levobupivacaine 0.5 mg/kg plus 0.9% isotonic (Group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 1?g/kg dexmedetomidine plus 0.9% isotonic (Group 3)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.9% isotonic 20 ml (Group 1)
Number of subjects: 60
Study: 34893026

Group type: COMPARATOR
Intervention: General anesthesia with patient-controlled intravenous analgesia (PCIA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: General anesthesia with patient-controlled epidural analgesia (PCEA)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: General anesthesia with continuous erector spinae plane block (ESPB) and PCIA
Number of subjects: 120
Study: 33808849

Group type: EXPERIMENTAL
Intervention: Traditional Thai Massage (TTM) - six weekly 1‐h sessions
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rest (Control)
Number of subjects: 12
Study: 32458080

Group type: EXPERIMENTAL
Intervention: Combined 308-nm excimer lamp and topical mometasone furoate cream
Number of subjects: 16

Group type: COMPARATOR
Intervention: 308-nm excimer lamp alone (monotherapy)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 16
Study: 34620069

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine/Ketamine (DK)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Propofol/Fentanyl (PF)
Number of subjects: 64
Study: 35262401

Group type: EXPERIMENTAL
Intervention: Dual-lumen flexible ureteroscope (DLFU)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Single-lumen flexible ureteroscope (SLFU)
Number of subjects: 79
Study: 32450253

Group type: EXPERIMENTAL
Intervention: SLSI-1216
Number of subjects: 0
Study: 36454561

Group type: EXPERIMENTAL
Intervention: BRIGHT (tele-cognitive behavioral therapy)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Attention Control (AC)
Number of subjects: 44
Study: 33694141

Group type: EXPERIMENTAL
Intervention: Mercurius corrosivus (Merc-c.) at potency levels 24x-30x
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water controls (unsuccussed or succussed water)
Number of subjects: 0
Study: 32271671

Group type: EXPERIMENTAL
Intervention: Chemoendocrine therapy (CT+E)
Number of subjects: 552

Group type: COMPARATOR
Intervention: Endocrine therapy alone (E)
Number of subjects: 552
Study: 35416182

Group type: EXPERIMENTAL
Intervention: 6 g fish oil daily for 6 weeks
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 6 g soybean oil daily for 6 weeks
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 3 g each fish and soybean oil daily for 6 weeks
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Baseline mtDNA gene expression
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Changes in mtDNA gene expression
Number of subjects: 68
Study: 32739509

Group type: EXPERIMENTAL
Intervention: Sulodexide (oral dose twice a day for 7 days before sclerotherapy, continued for 3 months)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Standard sclerotherapy protocol (Polidocanol as sclerosing agent, 20 to 30 mm Hg compression stockings for 7 days)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Sulodexide
Number of subjects: 720

Group type: COMPARATOR
Intervention: Standard sclerotherapy protocol
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Sulodexide and Standard sclerotherapy
Number of subjects: 720
Study: 35972853

Group type: EXPERIMENTAL
Intervention: Oral PrEP
Number of subjects: 260
Study: 32222821

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 324

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 324
Study: 32478030

Group type: EXPERIMENTAL
Intervention: Video treatment group (watching a 5-min video about the possible health hazards of MP use)
Number of subjects: 703

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 703
Study: 34023515

Group type: EXPERIMENTAL
Intervention: HN-STAR intervention
Number of subjects: 0
Study: 32666067

Group type: EXPERIMENTAL
Intervention: Fiber posts (FRC Postec Plus, Ivoclar Vivadent) luted using self‐adhesive composite cement (SpeedCEM Plus, Ivoclar Vivadent)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group: Root canals sealed using Acroseal (Septodont, France) and gutta‐percha, followed by composite resin for coronal restoration (Evetric, Ivoclar Vivadent)
Number of subjects: 20
Study: 36064731

Group type: EXPERIMENTAL
Intervention: Immediate group with access to the wristband solution and standard care
Number of subjects: 170

Group type: COMPARATOR
Intervention: Delayed group with access to standard care only
Number of subjects: 170
Study: 33075546

Group type: EXPERIMENTAL
Intervention: Subsequent exudative nAMD developed in 73 eyes (9.6%) of the incident GA cohort over a mean follow-up of 2.3 years.
Number of subjects: 1213

Group type: EXPERIMENTAL
Intervention: Subsequent exudative nAMD developed in 63 eyes (13.8%) of the prevalent GA cohort over a mean follow-up of 4.1 years.
Number of subjects: 1213
Study: 32960242

Group type: EXPERIMENTAL
Intervention: Prophylactic negative pressure wound therapy (n = 816, median duration 4 days)
Number of subjects: 1624

Group type: COMPARATOR
Intervention: Standard wound dressing (n = 808)
Number of subjects: 1624

Group type: EXPERIMENTAL
Intervention: Prophylactic negative pressure wound therapy
Number of subjects: 1624

Group type: COMPARATOR
Intervention: Standard wound dressing
Number of subjects: 1624
Study: 37081533

Group type: EXPERIMENTAL
Intervention: check‐up 45+
Number of subjects: 1654

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 1654
Study: 33340964

Group type: EXPERIMENTAL
Intervention: Pesticide training program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32768635

Group type: EXPERIMENTAL
Intervention: Expressive regulation (enhancement and suppression abilities)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Peer exclusion (manipulated through a Cyberball game)
Number of subjects: 247
Study: 35677636

Group type: EXPERIMENTAL
Intervention: Compound lactic acid bacteria capsules combined with escitalopram
Number of subjects: 60

Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 60
Study: 32910152

Group type: EXPERIMENTAL
Intervention: Adjuvanted recombinant zoster vaccine (RZV)
Number of subjects: 1943

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1943
Study: 35465007

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.2‐0.7 μg/kg/h)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 36
Study: 34215275

Group type: EXPERIMENTAL
Intervention: EIRA intervention (multiple health behaviour change intervention)
Number of subjects: 3062

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 3062

Group type: EXPERIMENTAL
Intervention: EIRA intervention
Number of subjects: 3062
Study: 35538431

Group type: EXPERIMENTAL
Intervention: 1000 mg/day resveratrol
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 33280541

Group type: EXPERIMENTAL
Intervention: Spatial distance manipulation
Number of subjects: 205
Study: 36353267

Group type: EXPERIMENTAL
Intervention: Neuroaspis plp10
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 32532601

Group type: EXPERIMENTAL
Intervention: Individualized homoeopathic treatment (11 medicines prescribed in potencies from 6C to 1M)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 84
Study: 32039984

Group type: EXPERIMENTAL
Intervention: Infant massage video instruction before observation
Number of subjects: 98

Group type: COMPARATOR
Intervention: Infant massage video instruction after observation
Number of subjects: 98
Study: 35915473

Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (individually-tailored, text-message and website-delivered, Spanish-language intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Original Intervention (web-based Pasos Hacia La Salud Intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced Intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both study arms
Number of subjects: 0
Study: 34687634

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg daily for 12 months
Number of subjects: 211

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 211
Study: 32657437

Group type: EXPERIMENTAL
Intervention: 5% Niacinamide (Nam)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 40
Study: 34741749

Group type: EXPERIMENTAL
Intervention: US-based radiomics model
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Final nomogram
Number of subjects: 548

Group type: COMPARATOR
Intervention: Clinical and conventional US model
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Final nomogram in contrast-enhanced US
Number of subjects: 548
Study: 33483435

Group type: EXPERIMENTAL
Intervention: Caffeine, CPAP, and surfactant via the LISA method
Number of subjects: 180

Group type: COMPARATOR
Intervention: Caffeine and CPAP alone
Number of subjects: 180
Study: 33301009

Group type: EXPERIMENTAL
Intervention: 3.3 mL/kg of concentrated beetroot juice containing 200 µmol/kg of nitrate
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 3.3 mL/kg of concentrated beetroot juice containing 400 µmol/kg of nitrate
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Higher dose of nitrate
Number of subjects: 9
Study: 32484441

Group type: EXPERIMENTAL
Intervention: Facebook educational program (n=40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Email educational program (n=40)
Number of subjects: 80
Study: 35643988

Group type: EXPERIMENTAL
Intervention: Three treatments with CPM‐HA20G (total 3 ml per side)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: One treatment with CPM‐HA20G (total 1.5 ml per side)
Number of subjects: 15
Study: 32978705

Group type: EXPERIMENTAL
Intervention: Treadmill slip‐perturbation training (Tt)
Number of subjects: 152
Study: 32687763

Group type: EXPERIMENTAL
Intervention: Guselkumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35718807

Group type: EXPERIMENTAL
Intervention: 940 nm diode laser (1 W, continuous-wave)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 2780 nm Er,Cr:YSGG laser (1.5 W, 30 Hz)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 17
Study: 33745609

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (500 mg daily for 8 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 34848344

Group type: EXPERIMENTAL
Intervention: [18F]‐NaF PET/MR
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard of Care (SOC) including clinical examination and conventional MRI
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Infiltration of all facet joints being PET/MR‐positive
Number of subjects: 39
Study: 33044240

Group type: EXPERIMENTAL
Intervention: Antifungal drugs in high-risk critically ill patients without microbiologic documentation of Candida infection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Routine universal screening for complications in candidemic patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher doses of echinocandins for treating invasive candidiasis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of fungal biomarkers for early initiation or interruption of antifungal therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted screening of eye infection and endocarditis with fungal biomarkers
Number of subjects: 0
Study: 35871331

Group type: EXPERIMENTAL
Intervention: SpeedCourt® system
Number of subjects: 39

Group type: COMPARATOR
Intervention: Fitfor100 program
Number of subjects: 39
Study: 34560265

Group type: EXPERIMENTAL
Intervention: SaMBA-COPD intervention with lay health coaches, including referral to a pharmacist for antibiotic and oral steroid rescue packs and support for a structured home exercise routine.
Number of subjects: 58

Group type: COMPARATOR
Intervention: COPD education control
Number of subjects: 58
Study: 33637618

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of conbercept (0.25 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intravitreal injection of ranibizumab (0.25 mg)
Number of subjects: 30
Study: 34540595

Group type: EXPERIMENTAL
Intervention: Internet-based self-help intervention (8 modules based on cognitive behavioral therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bibliotherapy (active control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internet-based self-help intervention
Number of subjects: 0
Study: 32593487

Group type: EXPERIMENTAL
Intervention: Tantalum acetabular component
Number of subjects: 66

Group type: COMPARATOR
Intervention: Titanium acetabular component with ancillary screw fixation
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups (Tantalum and Titanium)
Number of subjects: 66
Study: 35758093

Group type: EXPERIMENTAL
Intervention: 100 mg/day aspirin (ASA)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study: 32345787

Group type: EXPERIMENTAL
Intervention: Vaginal CO2 laser treatment
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 88
Study: 33527137

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 312

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study: 32106176

Group type: EXPERIMENTAL
Intervention: Periodized Resistance Training (PRD)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Nonperiodized Resistance Training (NPRD)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No-Resistance Training (NRT)
Number of subjects: 49
Study: 33970455

Group type: EXPERIMENTAL
Intervention: Centhaquine (0.01 mg/kg in 100 ml normal saline infusion over 1 h)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (100 ml normal saline infusion over 1 h)
Number of subjects: 50
Study: 32546239

Group type: EXPERIMENTAL
Intervention: Probiotic treatment for 6 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 36351635

Group type: EXPERIMENTAL
Intervention: Video calls with dispatchers
Number of subjects: 70

Group type: COMPARATOR
Intervention: Voice calls with dispatchers
Number of subjects: 70
Study: 33303479

Group type: EXPERIMENTAL
Intervention: Articles using ORs in AJPH
Number of subjects: 6124

Group type: EXPERIMENTAL
Intervention: Articles using ORs in NEJM
Number of subjects: 6124

Group type: EXPERIMENTAL
Intervention: Articles using ORs in PLOS One
Number of subjects: 6124

Group type: EXPERIMENTAL
Intervention: Articles using ORs in JAMA
Number of subjects: 6124

Group type: EXPERIMENTAL
Intervention: Any articles reporting effect size
Number of subjects: 6124

Group type: EXPERIMENTAL
Intervention: Articles reporting any effect size
Number of subjects: 6124

Group type: EXPERIMENTAL
Intervention: Articles with correct effect size interpretation
Number of subjects: 6124
Study: 35964235

Group type: EXPERIMENTAL
Intervention: CAD/CAM retainers
Number of subjects: 181

Group type: COMPARATOR
Intervention: Conventional retainers
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 181
Study: 33931900

Group type: EXPERIMENTAL
Intervention: Gliadin-protected SOD (GP-SOD; 1 g/day for 12 weeks followed by 0.5 g/day for 12 weeks) + NB-UVB
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo + NB-UVB
Number of subjects: 50
Study: 32065006

Group type: EXPERIMENTAL
Intervention: THC:CBD oromucosal spray (nabiximols)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32958502

Group type: EXPERIMENTAL
Intervention: Home-based HRV-BF with resonant breathing (n=25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study: 33306873

Group type: EXPERIMENTAL
Intervention: Drachman criteria
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Mantegazza criteria
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Suh criteria
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: International Consensus Guideline (ICG)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: REGAIN criteria
Number of subjects: 237
Study: 35723751

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide + 2% chlorhexidine-gel (Ca(OH)2 + 2% CHX-gel)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Calcium hydroxide + saline solution (Ca(OH)2 + SSL)
Number of subjects: 36
Study: 34426469

Group type: EXPERIMENTAL
Intervention: Lymph Node Ratio (LNR)
Number of subjects: 1038

Group type: EXPERIMENTAL
Intervention: Log Odds of Positive Lymph Nodes (LODDS)
Number of subjects: 1038

Group type: COMPARATOR
Intervention: Traditional N staging method
Number of subjects: 1038
Study: 32741790

Group type: EXPERIMENTAL
Intervention: Rehabilitation robot training (RRT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional occupational therapy
Number of subjects: 40
Study: 35395555

Group type: EXPERIMENTAL
Intervention: Soy nut consumption (67 g/day providing 25.5 g protein and 174 mg isoflavones)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Soy nut consumption (67 g/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (no nuts)
Number of subjects: 23
Study: 32147256

Group type: COMPARATOR
Intervention: Milk replacer without fatty acid supplementation and without access to a dry teat (control)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Milk replacer with fatty acid supplementation (NeoTec5g, Provimi, Brookville, OH) and without access to a dry teat (FAS)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Milk replacer without fatty acid supplementation and with access to a dry teat (TT)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Milk replacer with fatty acid supplementation and with access to a dry teat (FAS+TT)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: All interventions (FAS, TT, FAS+TT)
Number of subjects: 240
Study: 34311336

Group type: EXPERIMENTAL
Intervention: Vibwife moving mattress used for 10 minutes
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vibwife moving mattress used for 20 minutes
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vibwife moving mattress used for 30 minutes
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vibwife moving mattress overall
Number of subjects: 50
Study: 35164857

Group type: EXPERIMENTAL
Intervention: Break Free smoking cessation program
Number of subjects: 510
Study: 33415523

Group type: EXPERIMENTAL
Intervention: E group (with Humulus lupulus)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: E and D groups (with Humulus lupulus)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: W-D, N-D, W-E, and N-E groups (with different molting methods)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Molting programs (various groups)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Post-molting period (after applying molting methods)
Number of subjects: 252

Group type: COMPARATOR
Intervention: White button mushroom residual (for forced molting)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Hop (in second laying cycle)
Number of subjects: 252
Study: 32174033

Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT) in conjunction with carpal tunnel release surgery (CTRS)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Carpal tunnel release surgery (CTRS) alone
Number of subjects: 35
Study: 36038277

Group type: EXPERIMENTAL
Intervention: Trauma-informed medicolegal training
Number of subjects: 1060
Study: 34517775

Group type: EXPERIMENTAL
Intervention: Polypharmacy (taking ?5 medications)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Potentially inappropriate medication (PIM) use
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Anticholinergic score ?1
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Correlation between number of medications and number of PIMs
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Correlation between number of medications and anticholinergic score
Number of subjects: 168
Study: 34268888

Group type: EXPERIMENTAL
Intervention: Large volume subcutaneous injection (1, 8, and 20 cP viscosities, up to 10ml in abdomen and 5ml in thigh)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Large volume subcutaneous injection
Number of subjects: 32
Study: 34790138

Group type: EXPERIMENTAL
Intervention: Betahistine (72 mg/d)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 35835135

Group type: EXPERIMENTAL
Intervention: Doxorubicin plus trabectedin (60 mg/m2 doxorubicin and 1.1 mg/m2 trabectedin)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Doxorubicin alone (75 mg/m2)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Doxorubicin plus trabectedin
Number of subjects: 150

Group type: COMPARATOR
Intervention: Doxorubicin alone
Number of subjects: 150
Study: 33749741

Group type: EXPERIMENTAL
Intervention: Intravenous 8‐mg dose of dexamethasone
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study: 33090380

Group type: EXPERIMENTAL
Intervention: P‐Ser treatment for 12 months
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo treatment for 12 months
Number of subjects: 51